Marfloxin 5 mg Tablets for Cats and Dogs
Country: Netherlands
Language: English
Source: HMA (Heads of Medicines Agencies)
Summary of Product characteristics
(SPC)
10-01-2013
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
marbofloxacin 5 mg
Available from:
Krka d.d.
ATC code:
QJ01MA93
Pharmaceutical form:
Tablet
Therapeutic group:
marbofloxacin
Therapeutic area:
Cats, Dogs
Authorization date:
2012-11-21
Summary of Product characteristics
Issued: April 2013
AN: 01879/2011
:
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Marfloxin 5 mg tablets for cats and dogs
Quiflox 5 mg tablets for cats and dogs
Quiflox vet 5 mg tablets for cats and dogs
Marbiflox 5 mg tablets for cats and dogs
Marfloxin 5 mg tablets for cats and dogs (Austria, Belgium, Bulgaria, Estonia,
Germany, Greece, Italy, Ireland, Netherlands, Poland, Portugal, Romania, Slovenia,
Spain, United Kingdom)
Quiflox 5 mg tablets for cats and dogs (Czech Republic, Hungary, Latvi a, Lithuania,
Slovak Republic)
Quiflox vet 5 mg tablets for cats and dogs (Finland, Sweden, Norway)
Marbiflox 5 mg tablets for cats and dogs(Denmark, France,)
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
ACTIVE SUBSTANCE:
Marbofloxacin…….5 mg
EXCIPIENTS:
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablets.
Light brownish yellow, round, biconvex, marble tablets with bevelled edges and with
possible dark and white spots, scored on one side.
The tablets can be divided into halves.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cats and dogs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of infections caused by strains of microorganisms susceptible to
marbofloxacin.
Issued: April 2013
AN: 01879/2011
:
Page 2 of 6
In dogs:
skin and soft tissue infections (skinfold pyoderma, impetigo, folliculitis,
furunculosis, cellulitis);
urinary tract infections (UTI) associated or not with prostatitis or epididymitis;
Read the complete document
